Seoulin Bioscience Market Cap

Seoulin Bioscience has a market cap or net worth of 59.32 billion as of January 30, 2026. Its market cap has decreased by -6.51% in one year.

Market Cap

59.32B

Enterprise Value

39.56B

Revenue

76.74B

Ranking

n/a

PE Ratio

30.20

Stock Price

6,720.00

Market Cap Chart

Since October 25, 2005, Seoulin Bioscience's market cap has decreased from 69.74B to 59.32B, a decrease of -14.95%. That is a compound annual growth rate of -0.80%.

Market Cap History

Date	Market Cap	% Change
Jan 29, 2026	59.32B	3.23%
Dec 30, 2025	57.46B	-6.51%
Dec 30, 2024	61.46B	-21.97%
Dec 28, 2023	78.77B	-19.25%
Dec 29, 2022	97.55B	-44.18%
Dec 30, 2021	174.75B	62.58%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
3billion	474.83B
Dx & Vx	320.88B
Cytogen	179.94B
GENINUS	136.41B
HLB PANAGENE Co., LTD.	85.30B
Green Cross Medical Science	84.68B
Protia	72.11B
GeneMatrix	49.45B

Market Cap Rankings